Nocutil (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Nocutil, is a vasopressin V2 receptor agonist presented as an oral tablet for oral use. It is used to manage central diabetes insipidus, nocturnal enuresis, hemophilia A and von Willebrand disease in appropriate patients. GNH USA supplies Nocutil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acetate acts on the vasopressin V2 receptor pathway to control water balance and coagulation factors. - Central diabetes insipidus: reduces excessive urine output by enhancing renal water reabsorption. - Nocturnal enuresis: decreases nighttime bedwetting by concentrating urine. - Hemophilia A: raises plasma factor VIII levels to improve clot formation. - Von Willebrand disease: elevates von Willebrand factor, aiding platelet adhesion and clot stability.

Desmopressin acetate may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Hyponatremia: mild reduction in serum sodium levels. - Headache: transient, often resolves without treatment. - Nausea or abdominal cramps: gastrointestinal discomfort. - Facial flushing or mild nasal congestion: temporary vascular effects.

Serious or Rare Side Effects: - Severe hyponatremia leading to seizures or coma. - Water intoxication with cerebral edema. - Allergic reactions such as rash, pruritus or anaphylaxis. - Thrombotic events in patients with pre‑existing clotting disorders.

Desmopressin acetate requires careful monitoring in several clinical situations. - Fluid intake: limit excessive water consumption to reduce hyponatremia risk. - Serum sodium: check baseline and periodic sodium levels, especially in the elderly. - Renal function: adjust use in patients with impaired kidney function. - Concomitant drugs: avoid simultaneous use with vasopressin antagonists or strong diuretics without supervision. - Pregnancy: safety not established; use only if benefits outweigh potential risks. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Desmopressin acetate can interact with several medicines that affect water balance or coagulation.

Major Interactions (Avoid): - Vasopressin antagonists (e.g., conivaptan, tolvaptan): block therapeutic effect. - Carbamazepine: accelerates desmopressin metabolism, reducing efficacy. - NSAIDs (high‑dose): increase risk of hyponatremia.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): may potentiate water retention. - Antihypertensives: additive hypotensive effect possible. - SSRIs or other serotonergic agents: slight increase in hyponatremia risk.